Correspondence
In reply. S. Ramachandran and I. J. Clifton, Department of Respiratory Medicine, Leeds General Infirmary, Leeds, United Kingdom; T. A. Collyns, Department of Microbiology, Leeds General Infirmary, Leeds, United Kingdom; J. P. Watson and S. B. Pearson, Department of Respiratory Medicine, Leeds General Infirmary, Leeds, United Kingdom
Refocus on the stability and quality of anti-tuberculosis formulations. Saranjit Singh, Hemant Bhutani, and Bhagwat Prasad, Department of Pharmaceutical Analysis, NIPER, SAS Nagar, India
In reply. Korngamon Rookkapan, Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, Thailand
Document Type: Letter Paper
Publication date: 01 September 2006
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content